177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
Introduction: 177 Lu-DOTATATE-based peptide receptor radionuclide therapy (PRRT) is a promising therapy for metastatic and/or inoperable pheochromocytoma and paraganglioma (PPGL). We aim to evaluate the efficacy and safety of and identify predictors of response to 177 Lu-DOTATATE therapy in metastat...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2020
|
| 在线阅读: | https://doi.org/10.1530/ec-20-0292 https://ec.bioscientifica.com/downloadpdf/journals/ec/9/9/EC-20-0292.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|